Company Quick10K Filing
Quick10K
CASI
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$3.17 96 $303
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-20 Enter Agreement
8-K 2019-11-13
8-K 2019-11-12 Earnings, Exhibits
8-K 2019-10-29 Other Events
8-K 2019-09-10 Officers, Exhibits
8-K 2019-08-23 Other Events, Exhibits
8-K 2019-08-09 Earnings, Exhibits
8-K 2019-07-19 Enter Agreement, Exhibits
8-K 2019-06-20 Officers, Shareholder Vote, Exhibits
8-K 2019-06-15 Enter Agreement, Exhibits
8-K 2019-05-15 Earnings, Exhibits
8-K 2019-04-16 Enter Agreement, Exhibits
8-K 2019-04-01 Officers, Exhibits
8-K 2019-03-29 Earnings, Exhibits
8-K 2019-03-07 Enter Agreement, Leave Agreement, Other Events, Exhibits
8-K 2019-02-19 Other Events, Exhibits
8-K 2019-01-24 Accountant
8-K 2018-12-03 Other Events, Exhibits
8-K 2018-11-16 Enter Agreement, Exhibits
8-K 2018-11-14 Earnings, Exhibits
8-K 2018-10-23 Other Events, Exhibits
8-K 2018-09-28 Officers, Exhibits
8-K 2018-09-24 Accountant, Exhibits
8-K 2018-09-11 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-08-14 Earnings, Exhibits
8-K 2018-06-11 Officers, Shareholder Vote, Exhibits
8-K 2018-03-19 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-03-13 Officers
8-K 2018-02-23 Enter Agreement, Exhibits
8-K 2018-02-07 Officers
8-K 2018-01-26 Enter Agreement, M&A, Other Events, Exhibits

CASI Financials

-

CASI Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comparables ($'000 Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Agenus AGEN -0 206,707 363,935 114,859 0 -117,011 -110,509 -107,571
Gritstone Oncology GRTS 356,190 228,180 45,802 3,684 0 -75,107 -70,910 247,470
Genocea Biosciences GNCA -0 70,762 32,324 0 0 -29,545 -28,365 -45,254
Osiris Therapeutics OSIR 401,894 101,502 22,974 77,314 104,685 36,901 12,407 385,527
Replimune Group REPL 437,276 143,541 13,389 0 0 -30,298 -30,141 397,276
Biocryst Pharmaceuticals BCRX 400,643 116,344 125,537 0 0 -125,712 -114,441 415,254
CASI CASI 290,023 117,090 7,816 0 0 -41,431 -41,069 219,771
Solid Biosciences SLDB 178,764 96,304 19,809 0 0 -97,048 -97,048 111,378
PDL Biopharma PDLI 365,260 890,461 225,037 129,404 80,876 44,096 68,334 80,319
Scholar Rock Holding SRRK 438,747 196,911 67,956 5,039 0 -49,008 -47,974 324,744
DBV Technologies DBVT 173,407 171,749 -0 0 0 0 0 96,171
La Jolla Pharmaceutical LJPC 227,310 169,894 182,487 17,752 15,245 -158,264 -158,264 102,955
Cel Sci CVM 267,425 28,485 27,338 0 0 -31,780 -31,283 257,940
Eiger Biopharmaceuticals EIGR -0 132,927 44,848 0 0 -68,361 -65,291 -28,402
Sutro Biopharma STRO 243,028 188,812 69,257 46,076 0 -39,773 -35,470 230,623
Compugen CGEN 149,026 53,180 15,937 0 0 0 0 142,560
Erytech Pharma ERYP 118,942 167,840 -0 0 0 0 0 118,942
LogicBio Therapeutics LOGC 294,144 68,030 4,619 0 0 -35,361 -35,124 268,542
ADMA Biologics ADMA 221,849 143,274 96,368 18,376 -22,067 -57,386 -47,412 220,733

Balance Sheet ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash8,04918,27117,22315,87215,13214,19913,08011,81710,6709,4597,9546,4245,13113,94518,53424,13727,09325,52923,36121,64043,49049,88866,21698,86784,20599,73470,252
Accounts Receivable669000024242400
Inventory673
PP&E3366160572551142402314872462452355122231691844922454485661,4191,2011,6171,5942,4371,9021,335
Assets8,97818,48717,53916,26215,50814,62013,48312,41011,31010,1868,5787,1025,82614,52518,96824,75727,71326,18224,13322,71645,10171,16287,711120,309113,410131,060117,090
Accounts Payable5056495993524025925746007559959698018847839469191,0651,1201,1831,2042,0881,5822,0901,7419681,3832,321
Long-Term Debt
Liabilities74379575050156575674311,57311,73212,01212,02711,83411,9149,8888,9448,7346,9296,9427,1077,1386,5613,5434,1896,9873,9486,8477,816
Stockholders' Equity8,23517,69316,78915,76114,94213,86412,739838-422-1,826-3,449-4,733-6,0874,63710,02416,02320,78419,24017,02615,57838,54067,61983,522113,321109,462104,19689,038
Income Statement ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue242400000000000000
Cost of Revenue
Gross Profit
R&D5068377945607246977848651,2239421,0191,3631,0141,0491,7279713,8471,6972,4561,8063,2742,6152,979
SG&A
Tax00
Net Income-1,136-1,852-1,442-1,451-1,616-21,538-1,597-1,803-2,095-1,605-1,794-3,292-1,693-1,700-2,409-1,614-5,048-3,591-5,860-8,756-9,265-8,159-15,251
Cash Flow ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-140-1,046-1,376-1,355-5,403-3,378-4,093-15,709-5,219-8,458
Cash Investing-13-40-529-19,327-571-135-1,740-252-19,966
Cash Financing10,37522423,73430,65021,27837,5352,80720,715-1